Anna Caliò

2.6k total citations · 1 hit paper
74 papers, 1.4k citations indexed

About

Anna Caliò is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Anna Caliò has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 40 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Anna Caliò's work include Renal cell carcinoma treatment (35 papers), Renal and related cancers (30 papers) and Cancer Genomics and Diagnostics (17 papers). Anna Caliò is often cited by papers focused on Renal cell carcinoma treatment (35 papers), Renal and related cancers (30 papers) and Cancer Genomics and Diagnostics (17 papers). Anna Caliò collaborates with scholars based in Italy, United States and Türkiye. Anna Caliò's co-authors include Matteo Brunelli, Guido Martignoni, Marco Chilosi, Diego Segala, Giampaolo Tortora, Emilio Bria, Sara Pilotto, Aldo Scarpa, Luisa Carbognin and Serena Pedron and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Anna Caliò

70 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Luisa Carbognin, Sara Pilotto et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Caliò Italy	22	830	599	560	296	239	74	1.4k
Audrey Mansuet‐Lupo France	22	722 0.9×	981 1.6×	462 0.8×	321 1.1×	181 0.8×	64	1.8k
Sheila F. Faraj United States	22	731 0.9×	474 0.8×	330 0.6×	207 0.7×	688 2.9×	56	1.5k
Sarah Chiang United States	27	1.2k 1.5×	398 0.7×	418 0.7×	193 0.7×	157 0.7×	81	2.3k
Takako Kiyokawa Japan	26	643 0.8×	418 0.7×	409 0.7×	335 1.1×	847 3.5×	68	2.6k
Yungan Tao France	27	660 0.8×	1.0k 1.7×	586 1.0×	248 0.8×	756 3.2×	112	2.3k
Karuna Garg United States	30	741 0.9×	454 0.8×	693 1.2×	417 1.4×	342 1.4×	60	2.5k
Thèrése Bocklage United States	23	396 0.5×	418 0.7×	497 0.9×	275 0.9×	221 0.9×	73	1.5k
Hossein Saboorian United States	15	383 0.5×	451 0.8×	302 0.5×	367 1.2×	129 0.5×	24	1.1k
Jau‐Yu Liau Taiwan	25	414 0.5×	841 1.4×	488 0.9×	256 0.9×	422 1.8×	79	1.7k
Mariza de Peralta‐Venturina United States	13	717 0.9×	330 0.6×	495 0.9×	278 0.9×	476 2.0×	25	1.2k

Countries citing papers authored by Anna Caliò

Since Specialization

Citations

This map shows the geographic impact of Anna Caliò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Caliò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Caliò more than expected).

Fields of papers citing papers by Anna Caliò

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Caliò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Caliò. The network helps show where Anna Caliò may publish in the future.

Co-authorship network of co-authors of Anna Caliò

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Caliò. A scholar is included among the top collaborators of Anna Caliò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Caliò. Anna Caliò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simbolo, Michele, Alessandra Cocomazzi, Maria Liliana Piredda, et al.. (2025). ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR. Lung Cancer. 205. 108594–108594.

Marandino, Laura, Riccardo Bertolo, Alexandre Ingels, et al.. (2023). Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives. Diagnostics. 13(13). 2294–2294. 9 indexed citations

Caliò, Anna, Stefano Marletta, Matteo Brunelli, & Guido Martignoni. (2023). WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist. Pathologica. 115(1). 1–9. 17 indexed citations

Caliò, Anna, Stefano Marletta, Mimma Rizzo, et al.. (2023). mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(6). 821–833. 4 indexed citations

Ferrari, Filippo Alberto, Simone Garzon, Anna Caliò, et al.. (2022). 2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis. International Journal of Gynecological Cancer. 32. A214–A215. 1 indexed citations

Caliò, Anna, Stefano Marletta, Matteo Brunelli, et al.. (2022). TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(6). 877–891. 21 indexed citations

Belluomini, Lorenzo, Michele Simbolo, Riccardo Nocini, et al.. (2021). Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned. Cells. 10(10). 2685–2685. 4 indexed citations

Caliò, Anna, Matteo Brunelli, Stefano Marletta, et al.. (2021). Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai. Pathologica. 113(5). 307–315. 4 indexed citations

Pasello, Giulia, Jessica Menis, Sara Pilotto, et al.. (2020). How covid-19 pandemic impacted integrated care pathways for lung cancer: the experience of two Italian centers in veneto region. Tumori. 106. 73–74. 1 indexed citations

10.

Marletta, Stefano, Serena Ammendola, Mirko D’Onofrio, et al.. (2020). Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review. Journal of Gastrointestinal Cancer. 52(2). 771–775. 5 indexed citations

11.

Caliò, Anna, Matteo Brunelli, Diego Segala, et al.. (2020). Angiomyolipoma of the kidney: from simple hamartoma to complex tumour. Pathology. 53(1). 129–140. 27 indexed citations

12.

Girolami, Ilaria, Giovanni Gambaro, Claudio Ghimenton, et al.. (2019). Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys. Journal of Nephrology. 33(1). 167–176. 40 indexed citations

13.

Caliò, Anna, Matteo Brunelli, Diego Segala, et al.. (2018). VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations. Modern Pathology. 32(2). 258–268. 32 indexed citations

14.

Caliò, Anna, Maria Cecilia Mengoli, Alberto Cavazza, et al.. (2018). Cathepsin K expression in clear cell “sugar” tumor (PEComa) of the lung. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(1). 55–59. 12 indexed citations

15.

Kouba, Erik, John N. Eble, David J. Grignon, et al.. (2016). High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment. Modern Pathology. 29(11). 1347–1357. 7 indexed citations

16.

Peretti, Umberto, Roberto Ferrara, Sara Pilotto, et al.. (2016). ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations. Respiratory Research. 17(1). 105–105. 9 indexed citations

17.

Caliò, Anna, Alberto Zamò, Maurilio Ponzoni, et al.. (2015). Cellular Senescence Markers p16INK4a and p21CIP1/WAF Are Predictors of Hodgkin Lymphoma Outcome. Clinical Cancer Research. 21(22). 5164–5172. 32 indexed citations

18.

Carbognin, Luisa, Sara Pilotto, Michèle Milella, et al.. (2015). Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers. PLoS ONE. 10(6). e0130142–e0130142. 375 indexed citations breakdown →

19.

Caliò, Anna, Alessia Nottegar, Eliana Gilioli, et al.. (2014). ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung. Journal of Thoracic Oncology. 9(5). 729–732. 46 indexed citations

20.

Ikeura, Tsukasa, Riccardo Manfredi, Giuseppe Zamboni, et al.. (2013). Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterology Journal. 1(4). 276–284. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact